AR081789A1 - Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel - Google Patents
Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la pielInfo
- Publication number
- AR081789A1 AR081789A1 ARP110102292A ARP110102292A AR081789A1 AR 081789 A1 AR081789 A1 AR 081789A1 AR P110102292 A ARP110102292 A AR P110102292A AR P110102292 A ARP110102292 A AR P110102292A AR 081789 A1 AR081789 A1 AR 081789A1
- Authority
- AR
- Argentina
- Prior art keywords
- extracts
- skin
- extract
- magp
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente divulgación se refiere a métodos para tratar, prevenir y mejorar el estado y la apariencia estética de la piel, especialmente tratar, prevenir, mejorar, reducir y/o eliminar líneas finas y/o arrugas de la piel, mediante la aplicación de un compuesto o extracto natural o una combinación de compuestos o extractos naturales que estimulan la expresión de la MAGP-1 y que mejora la apariencia de la piel envejecida y/o foto dañada. Las composiciones se aplican en forma tópica o son suministradas por medios directos a un sitio en la piel que lo necesita, en una cantidad eficaz para mejorar el estado y la apariencia estética de la piel.Reivindicación 8: Una composición para mejorar la apariencia estética de la piel humana que comprende: (i) un agente activo de MAGP-1 seleccionado del grupo integrado por: un extracto de Antidesma bunius, un extracto de Operculina turpethum, un extracto de Ixora chinensis, un extracto de Clerodendron IindIeyi, un compuesto que tiene la fórmula (1), un compuesto de fórmula (2), y sus combinaciones, y (ii) un vehículo cosméticamente aceptable. Reivindicación 17: La composición de acuerdo con la reivindicación 8, que además comprende un segundo agente activo de la MAGP-1 seleccionado del grupo integrado por extractos de Sesbania grandiflora, extractos de Amorphophallus campanulatus, extractos de Sapindus rarak, extractos de Tiliacora triandra, extractos de Thunbergia laurifolia, KFTK, ácido tiodipropiónico y sus monoésteres y diésteres de alquilo C1-4, y sus combinaciones.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36008310P | 2010-06-30 | 2010-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR081789A1 true AR081789A1 (es) | 2012-10-17 |
Family
ID=45399876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110102292A AR081789A1 (es) | 2010-06-30 | 2011-06-29 | Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel |
Country Status (13)
Country | Link |
---|---|
US (3) | US9132294B2 (es) |
EP (2) | EP3272329B1 (es) |
JP (1) | JP5850929B2 (es) |
CN (3) | CN104207991B (es) |
AR (1) | AR081789A1 (es) |
BR (1) | BR112012032082B1 (es) |
CA (1) | CA2799223C (es) |
ES (1) | ES2645243T3 (es) |
HK (1) | HK1199828A1 (es) |
MX (1) | MX2012013787A (es) |
PL (1) | PL2588593T3 (es) |
TW (2) | TWI495488B (es) |
WO (1) | WO2012005876A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100166677A1 (en) | 2008-12-30 | 2010-07-01 | Avon Products, Inc. | Use of Tiliacora Triandra in Cosmetics and Compositions Thereof |
MX368365B (es) | 2009-12-22 | 2019-09-30 | Avon Prod Inc | Composiciones estimuladoras de paxilina y usos cosmeticos de las mismas. |
US20110159125A1 (en) | 2009-12-29 | 2011-06-30 | Avon Products, Inc. | CGRP Compositions and Uses Thereof |
EP3272329B1 (en) | 2010-06-30 | 2020-09-16 | Avon Products, Inc. | Compositions and methods for stimulation magp-1 to improve the appearance of skin |
US8815265B2 (en) * | 2010-06-30 | 2014-08-26 | Avon Products, Inc. | Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds |
US8455518B2 (en) * | 2010-12-28 | 2013-06-04 | Avon Products, Inc. | Method of treating skin with microRNA modulators |
PL2659004T3 (pl) * | 2010-12-30 | 2017-12-29 | Avon Products, Inc. | Modulacja dyneiny w skórze |
KR102389984B1 (ko) * | 2011-04-21 | 2022-04-22 | 마리 케이 인코포레이티드 | 식물 추출물을 포함하는 국소 스킨 케어 제형 |
US10195136B2 (en) | 2011-08-24 | 2019-02-05 | Avon Products, Inc. | Collagen and elastin stimulating compositions and uses thereof |
WO2014038097A1 (en) * | 2012-09-07 | 2014-03-13 | Shiseido Company, Ltd. | Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator |
US9186316B2 (en) | 2012-12-11 | 2015-11-17 | Avon Products, Inc. | Stephanotis jasminoides extracts and methods of use |
WO2014092686A1 (en) * | 2012-12-11 | 2014-06-19 | Avon Products, Inc. | Stephanotis jasminoides extracts and methods of use |
TW201422246A (zh) | 2012-12-11 | 2014-06-16 | Avon Prod Inc | 藉由調節wipi-1改善皮膚老化外觀之方法 |
TW201422250A (zh) * | 2012-12-11 | 2014-06-16 | Avon Prod Inc | Nesprin-2表現調節劑之用途及其組合物 |
US20140161918A1 (en) * | 2012-12-11 | 2014-06-12 | Avon Products, Inc. | Use of Adipose Septa Protein Modulators and Compositions Thereof |
WO2014164047A1 (en) * | 2013-03-11 | 2014-10-09 | Avon Products, Inc | Antidesma bunius extracts and methods of use |
US20150374618A1 (en) * | 2013-03-14 | 2015-12-31 | Avon Products, Inc. | Hedyotis hedrotidea extracts for cosmetics |
US9514620B2 (en) | 2013-09-06 | 2016-12-06 | Immersion Corporation | Spatialized haptic feedback based on dynamically scaled values |
US10076479B1 (en) * | 2018-05-08 | 2018-09-18 | Avon Products, Inc. | Methods for treating skin |
US10328012B2 (en) * | 2015-03-05 | 2019-06-25 | Avon Products, Inc. | Methods for treating skin |
US20170252289A1 (en) * | 2016-03-04 | 2017-09-07 | Avon Products, Inc. | Hydroponic Tiliacora Triandra and Use Thereof |
US11346755B2 (en) | 2019-01-10 | 2022-05-31 | Travera, Inc. | Calibration of a functional biomarker instrument |
WO2022093684A1 (en) * | 2020-10-30 | 2022-05-05 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods of treating inflammatory lung diseases |
CN115721585A (zh) * | 2021-08-02 | 2023-03-03 | 百岳特美肤生物技术(上海)有限公司 | 大花田菁提取物用于强化肌肤屏障及减缓肌肤泛红的用途 |
US11530974B1 (en) | 2021-11-01 | 2022-12-20 | Travera, Inc. | Cellular measurement, calibration, and classification |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4322438A (en) | 1979-08-06 | 1982-03-30 | United States Of America | Method for the use of orally administered 13-cis-retinoic acid in the treatment of acne |
JPH04321615A (ja) * | 1991-04-19 | 1992-11-11 | Kose Corp | 皮膚外用剤 |
JP3319870B2 (ja) * | 1994-04-13 | 2002-09-03 | 一丸ファルコス株式会社 | 皮膚外用組成物及び浴用剤 |
IN178508B (es) * | 1994-05-17 | 1997-05-03 | Physic Technolosies Pvt Lt | |
US5834513A (en) | 1996-04-25 | 1998-11-10 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
US5847003A (en) | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
US6146640A (en) | 1998-08-31 | 2000-11-14 | Dyke; John Paul | Immune system catalyst |
US7108982B1 (en) * | 1999-02-19 | 2006-09-19 | University Of Iowa Research Foundation | Diagnostics and the therapeutics for macular degeneration |
DE19910704B4 (de) | 1999-03-10 | 2006-04-20 | Cognis Ip Management Gmbh | Kosmetische Zubereitungen und deren Verwendung |
GB9918023D0 (en) | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
JP2001316221A (ja) * | 2000-05-10 | 2001-11-13 | Naris Cosmetics Co Ltd | 抗老化剤および化粧料 |
JP4532706B2 (ja) * | 2000-09-08 | 2010-08-25 | 花王株式会社 | 化粧料 |
US20040067245A1 (en) * | 2000-12-20 | 2004-04-08 | Harish Mahalingam | Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
US20040156886A1 (en) | 2001-06-12 | 2004-08-12 | Yasuhisa Kose | Sheet-like patch agent |
JP2003113064A (ja) * | 2001-09-28 | 2003-04-18 | Ts Aasu:Kk | 皮膚外用剤 |
US20030091665A1 (en) | 2001-11-09 | 2003-05-15 | Avon Products, Inc | Topical cosmetic composition with skin rejuvenation benefits |
UA82835C2 (en) | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
JP2005531287A (ja) * | 2002-02-01 | 2005-10-20 | メッドスター、リサーチ、インスティテュート | 再狭窄およびアテローム性動脈硬化症の発症素因としてのエラスチン、フィブリリンおよび関連遺伝子の多型 |
ITMI20020632A1 (it) | 2002-03-27 | 2003-09-29 | Indena Spa | Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene |
US6884783B2 (en) * | 2002-05-03 | 2005-04-26 | Unigen Pharmaceuticals, Inc. | 7-Hydroxy chromones as potent antioxidants |
ITMI20021692A1 (it) | 2002-07-30 | 2002-10-29 | Indena Spa | Polisaccaride di echinacea angustifolia. |
ITMI20021691A1 (it) | 2002-07-30 | 2004-01-30 | Indena Spa | Estratti di echinacea angustifolia |
US7189419B2 (en) | 2002-12-17 | 2007-03-13 | Avon Products, Inc. | Use of active extracts to lighten skin, lips, hair, and/or nails |
US20040126344A1 (en) | 2002-12-26 | 2004-07-01 | Avon Products, Inc. | Compositions having glycolipid to lighten skin and alter post-inflammatory hyperpigmentation |
JP4954450B2 (ja) | 2004-06-14 | 2012-06-13 | ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス | 弾性繊維形成の不全、欠損又は無秩序による病状に対処するための、リシルオキシダーゼのアイソフォームの活性の誘導 |
JP4527451B2 (ja) | 2004-06-14 | 2010-08-18 | ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス | 弾性繊維の形成を刺激するための、loxl(リシルオキシダーゼ類似)アイソフォームの合成及び活性の刺激 |
US20060024390A1 (en) | 2004-07-27 | 2006-02-02 | Alex Schauss | Palm fiber-based dietary supplements |
JP5041569B2 (ja) * | 2004-09-01 | 2012-10-03 | 丸善製薬株式会社 | チロシナーゼ活性阻害剤、美白剤及び皮膚化粧料 |
GB0420888D0 (en) * | 2004-09-20 | 2004-10-20 | Photopharmica Ltd | Compounds and uses |
WO2006043788A1 (en) | 2004-10-20 | 2006-04-27 | Doosan Corporation | Composition for protection and improvement of skin, or reinforcing skin barrier function comprising phosphatidylserine |
BRPI0406040B1 (pt) | 2004-10-21 | 2018-09-11 | Fundacao Univ De Brasilia | compostos capazes de absorver radiação ultravioleta, composições contendo os mesmos e processos para sua preparação |
US7618662B2 (en) * | 2004-12-22 | 2009-11-17 | Avon Products, Inc | Use of natural plant extracts in cosmetic compositions |
US8221766B2 (en) * | 2004-12-22 | 2012-07-17 | Avon Products, Inc. | Use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products |
US7514092B2 (en) * | 2004-12-22 | 2009-04-07 | Avon Products, Inc. | Compositions and methods of their use for improving the condition and appearance of skin |
WO2006082763A1 (ja) * | 2005-02-07 | 2006-08-10 | Kyoto University | Danceまたはその発現を増強する因子による弾性線維再生の方法 |
JP2007026356A (ja) | 2005-07-21 | 2007-02-01 | Sony Corp | 情報処理装置、この情報処理装置における処理方法およびその方法をコンピュータに実行させるプログラム |
WO2007026356A2 (en) | 2005-08-29 | 2007-03-08 | Healor Ltd. | Methods and compositions for prevention and treatment of diabetic and aged skin |
WO2007029982A1 (en) | 2005-09-08 | 2007-03-15 | Amorepacific Corporation | Composition of skin external application for anti-aging |
US7060849B1 (en) | 2005-09-15 | 2006-06-13 | General Electric Company | Method for production of isocyanatosilanes |
KR100659138B1 (ko) | 2005-09-16 | 2006-12-19 | (주)아모레퍼시픽 | 유효성분으로 갈로카테킨 갈레이트를 함유하는 보습용피부외용제 조성물 |
US20070185038A1 (en) | 2005-09-30 | 2007-08-09 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin care actives |
BRPI0618926A2 (pt) * | 2005-11-25 | 2011-09-13 | Peplin Research Pty Ltd | uso de um composto de ingenol ou um sal farmaceuticamente aceitável do mesmo |
JP2007210915A (ja) * | 2006-02-08 | 2007-08-23 | Kose Corp | 皮膚外用剤 |
US8404648B2 (en) * | 2006-02-16 | 2013-03-26 | Sederma | Polypeptides KXK and their use |
KR20080025508A (ko) | 2006-09-18 | 2008-03-21 | 동부일렉트로닉스 주식회사 | 플래시 메모리 소자 및 그 제조 방법 |
US7642062B2 (en) * | 2006-12-29 | 2010-01-05 | Avon Products Inc. | Compositions and methods of their use for improving the condition and appearance of skin |
KR100857693B1 (ko) * | 2007-05-10 | 2008-09-08 | 삼성에스디아이 주식회사 | 액정 표시장치 |
JP5587777B2 (ja) | 2007-07-31 | 2014-09-10 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 線維症をモジュレートするマイクロrnaファミリー及びその使用 |
JP5472563B2 (ja) * | 2008-03-24 | 2014-04-16 | 沖縄県 | チロシナーゼ活性阻害剤およびこれを含有する美白化粧料 |
JP2010090069A (ja) * | 2008-10-09 | 2010-04-22 | Shiseido Co Ltd | 美白剤および皮膚外用剤 |
FR2939316B1 (fr) | 2008-12-05 | 2012-08-10 | Limousine D Applic Biolog Ditesilab Soc Ind | Utilisation cosmetique d'activateurs de l'autophagie des cellules cutanees. |
EP2379082B1 (en) | 2008-12-17 | 2016-02-10 | Ei, Inc. | Acne treatment powder foundation |
US7993629B2 (en) | 2008-12-23 | 2011-08-09 | Avon Products, Inc. | Topical compositions containing CIS-6-nonenol and its derivatives and methods for treating skin |
US20100166677A1 (en) * | 2008-12-30 | 2010-07-01 | Avon Products, Inc. | Use of Tiliacora Triandra in Cosmetics and Compositions Thereof |
US20100233128A1 (en) * | 2009-03-13 | 2010-09-16 | Mci Media Capital Inc. | Natural Skin Products Containing Dairy and Processes |
ES2422718T3 (es) | 2009-04-02 | 2013-09-13 | Merck Patent Gmbh | Derivados de piperidina y piperazina como inhibidores de la autotaxina |
CN101559033A (zh) * | 2009-05-20 | 2009-10-21 | 黎秋萍 | 草药花泡沫沐浴剂与护肤胶囊 |
JP6059859B2 (ja) | 2009-11-16 | 2017-01-11 | ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエスBASF Beauty Care Solutions France S.A.S. | 弾性繊維の形成を刺激するための、loxl(リシルオキシダーゼ類似)アイソフォームの合成及び活性の刺激 |
MX368365B (es) | 2009-12-22 | 2019-09-30 | Avon Prod Inc | Composiciones estimuladoras de paxilina y usos cosmeticos de las mismas. |
CA2793423C (en) | 2010-06-11 | 2015-09-15 | Avon Products, Inc. | Use of eclipta prostrata and other ppar-gamma inhibitors in cosmetics and compositions thereof |
US8815265B2 (en) | 2010-06-30 | 2014-08-26 | Avon Products, Inc. | Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds |
US8771758B2 (en) | 2010-06-30 | 2014-07-08 | Avon Products, Inc. | Use of Tiliacora triandra in cosmetics and compositions thereof |
EP3272329B1 (en) | 2010-06-30 | 2020-09-16 | Avon Products, Inc. | Compositions and methods for stimulation magp-1 to improve the appearance of skin |
US8455518B2 (en) | 2010-12-28 | 2013-06-04 | Avon Products, Inc. | Method of treating skin with microRNA modulators |
PL2659004T3 (pl) | 2010-12-30 | 2017-12-29 | Avon Products, Inc. | Modulacja dyneiny w skórze |
US8686013B2 (en) | 2011-08-25 | 2014-04-01 | Avon Products, Inc. | Cosmetic use of substituted amino heterocylic carbamoyl analogs and related compounds |
US9289365B2 (en) | 2011-10-24 | 2016-03-22 | Avon Products, Inc. | Compositions and methods for stimulating collagen synthesis in the skin |
WO2013090228A2 (en) | 2011-12-13 | 2013-06-20 | Avon Products, Inc. | Maesa japonica extracts and methods of use |
US8632827B2 (en) | 2011-12-13 | 2014-01-21 | Avon Products, Inc | Modulation of thymosin beta-4 in skin |
US9186316B2 (en) | 2012-12-11 | 2015-11-17 | Avon Products, Inc. | Stephanotis jasminoides extracts and methods of use |
US9034396B2 (en) | 2012-12-11 | 2015-05-19 | Avon Products, Inc. | Serissa japonica extracts and methods of use |
TW201422246A (zh) | 2012-12-11 | 2014-06-16 | Avon Prod Inc | 藉由調節wipi-1改善皮膚老化外觀之方法 |
-
2011
- 2011-06-13 EP EP17186761.7A patent/EP3272329B1/en active Active
- 2011-06-13 CN CN201410457703.7A patent/CN104207991B/zh active Active
- 2011-06-13 MX MX2012013787A patent/MX2012013787A/es active IP Right Grant
- 2011-06-13 PL PL11804011T patent/PL2588593T3/pl unknown
- 2011-06-13 US US13/158,947 patent/US9132294B2/en active Active
- 2011-06-13 ES ES11804011.2T patent/ES2645243T3/es active Active
- 2011-06-13 CA CA2799223A patent/CA2799223C/en active Active
- 2011-06-13 CN CN201710118718.4A patent/CN106727054A/zh not_active Withdrawn
- 2011-06-13 WO PCT/US2011/040157 patent/WO2012005876A2/en active Application Filing
- 2011-06-13 BR BR112012032082-3A patent/BR112012032082B1/pt active IP Right Grant
- 2011-06-13 CN CN2011800312402A patent/CN102959077A/zh active Pending
- 2011-06-13 JP JP2013518428A patent/JP5850929B2/ja active Active
- 2011-06-13 EP EP11804011.2A patent/EP2588593B1/en active Active
- 2011-06-28 TW TW100122703A patent/TWI495488B/zh active
- 2011-06-28 TW TW104119333A patent/TWI581809B/zh active
- 2011-06-29 AR ARP110102292A patent/AR081789A1/es active IP Right Grant
-
2013
- 2013-07-26 HK HK15100312.4A patent/HK1199828A1/xx unknown
-
2015
- 2015-09-09 US US14/848,443 patent/US9999587B2/en not_active Expired - Fee Related
-
2018
- 2018-05-31 US US15/994,164 patent/US10849840B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN106727054A (zh) | 2017-05-31 |
WO2012005876A3 (en) | 2012-03-15 |
TWI581809B (zh) | 2017-05-11 |
EP3272329B1 (en) | 2020-09-16 |
US20160008266A1 (en) | 2016-01-14 |
CN104207991A (zh) | 2014-12-17 |
WO2012005876A2 (en) | 2012-01-12 |
EP3272329A2 (en) | 2018-01-24 |
HK1199828A1 (en) | 2015-07-24 |
TW201534347A (zh) | 2015-09-16 |
PL2588593T3 (pl) | 2018-01-31 |
JP5850929B2 (ja) | 2016-02-03 |
EP2588593A4 (en) | 2015-12-09 |
CN104207991B (zh) | 2017-04-12 |
CN102959077A (zh) | 2013-03-06 |
US10849840B2 (en) | 2020-12-01 |
BR112012032082A2 (pt) | 2015-10-06 |
JP2013530224A (ja) | 2013-07-25 |
US20120003332A1 (en) | 2012-01-05 |
CA2799223C (en) | 2019-02-26 |
EP2588593A2 (en) | 2013-05-08 |
US9132294B2 (en) | 2015-09-15 |
EP2588593B1 (en) | 2017-08-23 |
ES2645243T3 (es) | 2017-12-04 |
MX2012013787A (es) | 2012-12-17 |
BR112012032082B1 (pt) | 2019-11-26 |
EP3272329A3 (en) | 2018-03-07 |
TW201206495A (en) | 2012-02-16 |
US20180271772A1 (en) | 2018-09-27 |
US9999587B2 (en) | 2018-06-19 |
CA2799223A1 (en) | 2012-01-12 |
TWI495488B (zh) | 2015-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR081789A1 (es) | Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel | |
WO2012085523A3 (en) | Skin sanitizer compositions comprising alcohol based emulsion | |
NZ596254A (en) | Cleanser compositions and methods for using the same comprising linalool, hinokitiol, diol and surfactant | |
AR081790A1 (es) | Un metodo para mejorar el aspecto estetico de la piel, uso de tiliacora triandra en cosmeticos y composiciones, metodo para obtencion del extracto | |
BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
MX2015012302A (es) | Composiciones tópicas y métodos de tratamiento para trastornos de la piel. | |
BR112012007257A2 (pt) | Uso de pelo menos um composto, processo de conservação de uma composição, composto e composições cosmética e dermatológica | |
CL2016000544A1 (es) | Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel. | |
AR088056A1 (es) | MODULACION DE TIMOSINA b-4 EN LA PIEL, METODO PARA MEJORAR EL ASPECTO ESTETICO DE LA PIEL, PARA TRATAR ARRUGAS, COMPOSICION COSMETICA | |
CL2011002648A1 (es) | Composicion topica que comprende un compuesto derivado de 1,2,4-tiadiazol o tiourea, un agente modificador de la viscosidad, un conservante y agua; estuche para la composicion; metodo para preparar la composicion; y uso para tratar una enfermedad o trastorno dermatologico mediado por un receptor de melanocortina tal como acne. | |
BR112015020049A8 (pt) | composição na forma de uma emulsão óleo-em-água e processos cosméticos | |
BR112014002594A2 (pt) | uso de diésteres de isossorbida como espessantes | |
MX2015003074A (es) | Formulaciones que comprenden idebenona, n-acetil-s-farnesil-l-cist eína y ergotioneína y usos de las mismas. | |
HRP20210323T1 (hr) | Pripravak za zaštitu od sunca | |
AR065317A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
RU2014130012A (ru) | Композиции, содержащие экстракт malva neglecta | |
MXPA06013179A (es) | Composicion anti-acne para el cuidado de la piel y articulo para el cuidado de la piel. | |
MX358394B (es) | Composicion cosmetica o dermatologica que comprende una merocianina, un agente de filtro ultravioleta b (uvb) organico y un agente de filtro ultravioleta a (uva) organico adicional. | |
BR112015027436A8 (pt) | composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos | |
MX2015009017A (es) | Composicion cosmetica o dermatologica que comprende una merocianina y un agente de filtro ultravioleta (uv) de benzotriazol, lipofilo y/o un compuesto de bis-resorcinil-triazina . | |
AR097216A1 (es) | Composición para el tratamiento contra el envejecimiento de la piel | |
AR094035A1 (es) | Estimulantes del colageno y su uso en el tratamiento de la piel | |
MX2015008711A (es) | Composicion cosmetica o dermatologica que comprende una merocianina y un agente de filtracion de los rayos ultravioleta a del tipo de 2-hidroxibenzofenona substituida con amino y/o un agente de filtracion de los rayos ultravioleta a organico, hidrofilico. | |
FR2973226B1 (fr) | Utilisation de composes (ethoxy-hydroxyphenyl)alkylcetone ou ethoxyhydroxyalkylphenol pour traiter la peau grasse | |
GB2489173A (en) | Multipurpose boat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |